scorecardresearch
Wednesday, August 13, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Expert panel of India’s drug regulator recommends approval for Bharat Biotech’s Covaxin

The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on Saturday deliberated on the emergency use authorisation application of Bharat Biotech.

Covid protection with placebo too? Bharat Biotech’s pitch for volunteers raises concerns

Bharat Biotech has asked Covaxin trial sites to offer Covid protection as an incentive to draw volunteers. Experts say it is unethical.

Bharat Biotech ‘thousands of volunteers short’ for ongoing Covaxin Phase 3 trials

Trial sites conducting Covaxin study say the company has given them an indicative deadline of 31 December to complete the recruitment of volunteers, but company denies claim.

Covaxin Phase 2 trials find Covid vaccine safe, no serious adverse events reported

Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

‘How do we get there?’ – Bharat Biotech readies for uphill task of Covid vaccine roll out

Bharat Biotech has already produced about 10 million doses of Covaxin shot, ahead of anticipated roll out next year. But task of supplying it seems daunting.

Covaxin Phase I trial results show vaccine is safe, generates immune response

In a preprint paper, researchers from Bharat Biotech, ICMR, AIIMS have reported the results of the trial on 375 participants. 

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

Over 60 foreign envoys visit Bharat Biotech, Biological E to see Covid vaccine progress

The Ambassadors and High Commissioners visited the facilities of the major pharma companies, which are involved in the manufacturing of Covid vaccine candidate, Covaxin.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

On Camera

Hrithik Roshan & Jr NTR in Janaab-e-Aali is exactly what a dance-off should not be

Forget comparing it with classics like Hrithik’s Ek Pal Ka Jeena or the slick title track of Dhoom 2, Janaab-e-Aali does not even come close to Ghungroo.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

India expands Southeast Asia defence footprint with new joint venture in Philippines

Memorandum of understanding between SMPP and ADFC was signed during state visit of Philippines’ President to India earlier this month.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.